Drug factory · FDA FEI 3008380269
Bliss GVS Pharma Limited
Plot No 11, Survey No 38, Gut No 312 Dewan Udyog Nagar, Aliyali Village, Palghar, India
Problems found, fixed voluntarily at FDA's last inspection, Mar 17, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2023: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Indomethacin | Makes it, tests it and packages it | Hikma Pharmaceuticals USA Inc. | 0054-1950 |
| Mesalamine | Makes it, tests it, packages it and labels it | Rising Pharma Holdings, Inc. | 16571-246 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 17, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.